Abstract:Abstract Motivation Artificial intelligence, trained via machine learning (e.g. neural nets, random forests) or computational statistical algorithms (e.g. support vector machines, ridge regression), holds much promise for the improvement of small-molecule drug discovery. However, small-molecule structure-activity data are high dimensional with low signal-to-noise ratios and proper validation of predictive methods is difficult. It is poorly understood which, if any, of the currently available machine learning algorithms will best predict new candidate drugs. Results The quantile-activity bootstrap is proposed as a new model validation framework using quantile splits on the activity distribution function to construct training and testing sets. In addition, we propose two novel rank-based loss functions which penalize only the out-of-sample predicted ranks of high-activity molecules. The combination of these methods was used to assess the performance of neural nets, random forests, support vector machines (regression) and ridge regression applied to 25 diverse high-quality structure-activity datasets publicly available on ChEMBL. Model validation based on random partitioning of available data favours models that overfit and ‘memorize’ the training set, namely random forests and deep neural nets. Partitioning based on quantiles of the activity distribution correctly penalizes extrapolation of models onto structurally different molecules outside of the training data. Simpler, traditional statistical methods such as ridge regression can outperform state-of-the-art machine learning methods in this setting. In addition, our new rank-based loss functions give considerably different results from mean squared error highlighting the necessity to define model optimality with respect to the decision task at hand. Availability and implementation All software and data are available as Jupyter notebooks found at https://github.com/owatson/QuantileBootstrap. Supplementary information Supplementary data are available at Bioinformatics online.

Efficient, adaptive cross-validation for tuning and comparing models, with application to drug discovery

Bootstrap Cross-validation Improves Model Selection in Pharmacometrics

Is Cross-Validation the Gold Standard to Evaluate Model Performance?

Bayesian cross-validation by parallel Markov chain Monte Carlo

Step Forward Cross Validation for Bioactivity Prediction: Out of Distribution Validation in Drug Discovery

Cross-Validation for Nonlinear Mixed Effects Models

Is K-fold cross validation the best model selection method for Machine Learning?

Monte Carlo Cross‐validation for Selecting a Model and Estimating the Prediction Error in Multivariate Calibration

Iterative Approximate Cross-Validation

Assessing Model Fit by Cross-Validation

Validating the validation: reanalyzing a large-scale comparison of deep learning and machine learning models for bioactivity prediction

Efficient Selection Between Hierarchical Cognitive Models: Cross-validation With Variational Bayes

A decision theoretic approach to model evaluation in computational drug discovery

Approximate Cross-validation: Guarantees for Model Assessment and Selection

Overview of model validation for survival regression model with competing risks using melanoma study data

A decision-theoretic approach to the evaluation of machine learning algorithms in computational drug discovery

Fast and Informative Model Selection using Learning Curve Cross-Validation

Consensus Features Nested Cross-Validation

Bayesian nonparametric cross-study validation of prediction methods

Don't Waste Your Time: Early Stopping Cross-Validation

Impact of Molecular Representations on Deep Learning Model Comparisons in Drug Response Predictions